Dr. Sylvie GrÃ©goire, President of Shire Human Genetic Therapies, presented at last year's World Orphan Drug Congress USA on the topic âThe social responsibility of companies working with orphan diseases.'
Do you want to learn more about:
- Differentiating the orphan drug market from the traditional pharma market
- Focusing on patients and personalized marketing: a paradigm shift to market drugs in orphan diseases
- Industry’s responsibility to provide patients with access to orphan drugs
If so, you need to check out the video below: